Iota Biosciences has raised about $15 million in a series A round to help further develop its millimeter-sized neural dust platform.
The company has had significant struggles with the EndoBarrier in the past, but a nod from FDA and the IRB to begin a new pivotal trial might be step back in the right direction for the technology.
In addition to J&J picking up Auris Health for $3.4 billion, Roger Smith, Phd, who follows the surgical robotics market closely, said we could continue to see large medtech companies making acquisitions in the space.
The two companies worked together to develop a smart cable and software module, which would enable compatibility between the FORE-SIGHT sensor and the HemoSphere platform.
The Fully Implanted Ventricular Assist Device was developed using technologies from Jarvik Heart and Leviticus Cardio.
The company said technology could not solve the opioid epidemic alone and described the One Fifteen solution as a “learning health system.”
Acutus Medical originally received a nod from FDA in 2017 and a CE mark in 2016 for the AcQMap cardiac imaging technology.
Anthony Chang, MD, said he believes that artificial intelligence is going to have a stronger impact in medtech in the coming years, and spoke about the growing trend, at a panel session on the opening day of MD&M West.
Edwards might be primarily known for its TAVR systems, but the company has been making some interesting forays into the artificial intelligence realm.
The Tempe, AZ-based company has raised $10M in a series A to help further commercialize the Gamma Tile, surgically targeted radiation therapy for patients with brain tumors.
Biodesix and MRM are the latest diagnostic firms to enter into a partnership geared at the early detection of lung cancer.
In addition, the company said it has received a breakthrough device designation for the test, which predicts amyloid PET scan results in patients.
The Marlborough, MA-based company’s device treats benign prostatic hyperplasia, and was obtained when it acquired NxThera for $406 million.